APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin API

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Selected research

Market Outlook & Growth Opportunities

Global Insulin API Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchInsulin API Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin API Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Insulin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

Read the full market overview

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

This report provides an overview of the global Insulin API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin API market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin API Segment by Company

Novo Nordisk

Sanofi-Aventis

Eli Lilly

Tonghua Dongbao

Ganlee

United Laboratory

Biocon

Amphastar

Wockhardt

Julphar Diabetes

Torrent Pharma

Insulin API Segment by Type

Regular Human Insulin

Insulin Analogue

Insulin API Segment by Application

Fast-Acting

Premix

Long-Acting

Insulin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Insulin API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Insulin API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Insulin API significant trends, drivers, influence factors in global and regions.

6. To analyze Insulin API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin API industry.

Chapter 3: Detailed analysis of Insulin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Insulin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Insulin API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Insulin API Industry Trends Table 2. Insulin API Industry Drivers Table 3. Insulin API Industry Opportunities and Challenges Table 4. Insulin API Industry Restraints Table 5. Global Insulin API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Insulin API Revenue Share by Company (2021-2026) Table 7. Global Insulin API Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Insulin API Sales Volume Share by Company (2021-2026) Table 9. Global Insulin API Average Price (K US$/Kg) of Company (2021-2026) Table 10. Global Insulin API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Insulin API Key Company Manufacturing Base & Headquarters Table 12. Global Insulin API Company, Product Type & Application Table 13. Global Insulin API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Regular Human Insulin Table 18. Significant Companies of Insulin Analogue Table 19. Global Insulin API Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Insulin API Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Insulin API Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Insulin API Sales Volume Share by Type (2021-2026) Table 23. Global Insulin API Sales Volume Share by Type (2027-2032) Table 24. Global Insulin API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Insulin API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Insulin API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Insulin API Sales Value Share by Type (2021-2026) Table 28. Global Insulin API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Fast-Acting Table 30. Significant Companies of Premix Table 31. Significant Companies of Long-Acting Table 32. Global Insulin API Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 33. Global Insulin API Sales Volume by Application (2021-2026) & (Kg) Table 34. Global Insulin API Sales Volume by Application (2027-2032) & (Kg) Table 35. Global Insulin API Sales Volume Share by Application (2021-2026) Table 36. Global Insulin API Sales Volume Share by Application (2027-2032) Table 37. Global Insulin API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Insulin API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Insulin API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Insulin API Sales Value Share by Application (2021-2026) Table 41. Global Insulin API Sales Value Share by Application (2027-2032) Table 42. Global Insulin API Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 43. Global Insulin API Sales by Region (2021-2026) & (Kg) Table 44. Global Insulin API Sales Market Share by Region (2021-2026) Table 45. Global Insulin API Sales by Region (2027-2032) & (Kg) Table 46. Global Insulin API Sales Market Share by Region (2027-2032) Table 47. Global Insulin API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Insulin API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Insulin API Sales Value Share by Region (2021-2026) Table 50. Global Insulin API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Insulin API Sales Value Share by Region (2027-2032) Table 52. Global Insulin API Market Average Price (K US$/Kg) by Region (2021-2026) Table 53. Global Insulin API Market Average Price (K US$/Kg) by Region (2027-2032) Table 54. Global Insulin API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 55. Global Insulin API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Insulin API Sales by Country (2021-2026) & (Kg) Table 57. Global Insulin API Sales Market Share by Country (2021-2026) Table 58. Global Insulin API Sales by Country (2027-2032) & (Kg) Table 59. Global Insulin API Sales Market Share by Country (2027-2032) Table 60. Global Insulin API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Insulin API Sales Value Market Share by Country (2021-2026) Table 62. Global Insulin API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Insulin API Sales Value Market Share by Country (2027-2032) Table 64. Novo Nordisk Company Information Table 65. Novo Nordisk Business Overview Table 66. Novo Nordisk Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 67. Novo Nordisk Insulin API Product Portfolio Table 68. Novo Nordisk Recent Development Table 69. Sanofi-Aventis Company Information Table 70. Sanofi-Aventis Business Overview Table 71. Sanofi-Aventis Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 72. Sanofi-Aventis Insulin API Product Portfolio Table 73. Sanofi-Aventis Recent Development Table 74. Eli Lilly Company Information Table 75. Eli Lilly Business Overview Table 76. Eli Lilly Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 77. Eli Lilly Insulin API Product Portfolio Table 78. Eli Lilly Recent Development Table 79. Tonghua Dongbao Company Information Table 80. Tonghua Dongbao Business Overview Table 81. Tonghua Dongbao Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 82. Tonghua Dongbao Insulin API Product Portfolio Table 83. Tonghua Dongbao Recent Development Table 84. Ganlee Company Information Table 85. Ganlee Business Overview Table 86. Ganlee Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 87. Ganlee Insulin API Product Portfolio Table 88. Ganlee Recent Development Table 89. United Laboratory Company Information Table 90. United Laboratory Business Overview Table 91. United Laboratory Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 92. United Laboratory Insulin API Product Portfolio Table 93. United Laboratory Recent Development Table 94. Biocon Company Information Table 95. Biocon Business Overview Table 96. Biocon Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 97. Biocon Insulin API Product Portfolio Table 98. Biocon Recent Development Table 99. Amphastar Company Information Table 100. Amphastar Business Overview Table 101. Amphastar Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 102. Amphastar Insulin API Product Portfolio Table 103. Amphastar Recent Development Table 104. Wockhardt Company Information Table 105. Wockhardt Business Overview Table 106. Wockhardt Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 107. Wockhardt Insulin API Product Portfolio Table 108. Wockhardt Recent Development Table 109. Julphar Diabetes Company Information Table 110. Julphar Diabetes Business Overview Table 111. Julphar Diabetes Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 112. Julphar Diabetes Insulin API Product Portfolio Table 113. Julphar Diabetes Recent Development Table 114. Torrent Pharma Company Information Table 115. Torrent Pharma Business Overview Table 116. Torrent Pharma Insulin API Sales (Kg), Value (US$ Million), Price (K US$/Kg) and Gross Margin (2021-2026) Table 117. Torrent Pharma Insulin API Product Portfolio Table 118. Torrent Pharma Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Insulin API Distributors List Table 122. Insulin API Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Insulin API Product Image Figure 2. Global Insulin API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Insulin API Sales (2021-2032) & (Kg) Figure 5. Global Insulin API Sales Average Price (K US$/Kg) & (2021-2032) Figure 6. Global Insulin API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Regular Human Insulin Image Figure 10. Insulin Analogue Image Figure 11. Global Insulin API Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Insulin API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Insulin API Sales Volume Share by Type (2021-2032) Figure 14. Global Insulin API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Insulin API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Insulin API Sales Value Share by Type (2021-2032) Figure 17. Fast-Acting Image Figure 18. Premix Image Figure 19. Long-Acting Image Figure 20. Global Insulin API Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Insulin API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Insulin API Sales Volume Share by Application (2021-2032) Figure 23. Global Insulin API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Insulin API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Insulin API Sales Value Share by Application (2021-2032) Figure 26. Global Insulin API Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global Insulin API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Insulin API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Insulin API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Insulin API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Insulin API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Insulin API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Insulin API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Insulin API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Insulin API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Insulin API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Insulin API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Insulin API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Insulin API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Insulin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Insulin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Insulin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Insulin API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Insulin API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Human Insulin
  • Insulin Analogue
Applications
  • Fast-Acting
  • Premix
  • Long-Acting
Companies covered
  • Novo Nordisk
  • Sanofi-Aventis
  • Eli Lilly
  • Tonghua Dongbao
  • Ganlee
  • United Laboratory
  • Biocon
  • Amphastar
  • Wockhardt
  • Julphar Diabetes
  • Torrent Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin API Sales Value (2021-2032)
  4. 1.2.2 Global Insulin API Sales Volume (2021-2032)
  5. 1.2.3 Global Insulin API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Insulin API Market Dynamics
  1. 2.1 Insulin API Industry Trends
  2. 2.2 Insulin API Industry Drivers
  3. 2.3 Insulin API Industry Opportunities and Challenges
  4. 2.4 Insulin API Industry Restraints
3 Insulin API Market by Company
  1. 3.1 Global Insulin API Company Revenue Ranking in 2025
  2. 3.2 Global Insulin API Revenue by Company (2021-2026)
  3. 3.3 Global Insulin API Sales Volume by Company (2021-2026)
  4. 3.4 Global Insulin API Average Price by Company (2021-2026)
  5. 3.5 Global Insulin API Company Ranking (2024-2026)
  6. 3.6 Global Insulin API Company Manufacturing Base and Headquarters
  7. 3.7 Global Insulin API Company Product Type and Application
  8. 3.8 Global Insulin API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Insulin API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Insulin API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Insulin API Market by Type
  1. 4.1 Insulin API Type Introduction
  2. 4.1.1 Regular Human Insulin
  3. 4.1.2 Insulin Analogue
  4. 4.2 Global Insulin API Sales Volume by Type
  5. 4.2.1 Global Insulin API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Insulin API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Insulin API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Insulin API Sales Value by Type
  9. 4.3.1 Global Insulin API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Insulin API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Insulin API Sales Value Share by Type (2021-2032)
5 Insulin API Market by Application
  1. 5.1 Insulin API Application Introduction
  2. 5.1.1 Fast-Acting
  3. 5.1.2 Premix
  4. 5.1.3 Long-Acting
  5. 5.2 Global Insulin API Sales Volume by Application
  6. 5.2.1 Global Insulin API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Insulin API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Insulin API Sales Value by Application
  10. 5.3.1 Global Insulin API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Insulin API Sales Value Share by Application (2021-2032)
6 Insulin API Regional Sales and Value Analysis
  1. 6.1 Global Insulin API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin API Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin API Sales by Region: 2021-2026
  4. 6.2.2 Global Insulin API Sales by Region (2027-2032)
  5. 6.3 Global Insulin API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Insulin API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Insulin API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Insulin API Sales Value by Region (2027-2032)
  9. 6.5 Global Insulin API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Insulin API Sales Value (2021-2032)
  12. 6.6.2 North America Insulin API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Insulin API Sales Value (2021-2032)
  15. 6.7.2 Europe Insulin API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Insulin API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Insulin API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Insulin API Sales Value (2021-2032)
  21. 6.9.2 South America Insulin API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Insulin API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Insulin API Sales Value Share by Country, 2025 VS 2032
7 Insulin API Country-level Sales and Value Analysis
  1. 7.1 Global Insulin API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Insulin API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Insulin API Sales by Country (2021-2032)
  4. 7.3.1 Global Insulin API Sales by Country (2021-2026)
  5. 7.3.2 Global Insulin API Sales by Country (2027-2032)
  6. 7.4 Global Insulin API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Insulin API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Insulin API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Insulin API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Insulin API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Insulin API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Insulin API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Insulin API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Insulin API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Insulin API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Insulin API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Insulin API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Insulin API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Insulin API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Insulin API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Insulin API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Insulin API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Insulin API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Insulin API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Insulin API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Insulin API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Insulin API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Insulin API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Insulin API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Insulin API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Insulin API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Insulin API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Insulin API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Insulin API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Insulin API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Insulin API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Insulin API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Insulin API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Insulin API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Insulin API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Insulin API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Insulin API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Insulin API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Insulin API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Insulin API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Insulin API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Insulin API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Insulin API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Insulin API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Insulin API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Insulin API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Insulin API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Insulin API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Insulin API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Insulin API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Insulin API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Insulin API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Insulin API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Insulin API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Insulin API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Insulin API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Insulin API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Insulin API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Insulin API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Insulin API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Insulin API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Insulin API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Insulin API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Insulin API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Insulin API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Insulin API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Insulin API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Insulin API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Insulin API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Insulin API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Insulin API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Insulin API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Insulin API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Insulin API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Insulin API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Insulin API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Insulin API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Insulin API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Insulin API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Insulin API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Insulin API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Insulin API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Insulin API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Insulin API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Insulin API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Insulin API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Insulin API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Insulin API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Insulin API Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Sanofi-Aventis
  8. 8.2.1 Sanofi-Aventis Company Information
  9. 8.2.2 Sanofi-Aventis Business Overview
  10. 8.2.3 Sanofi-Aventis Insulin API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi-Aventis Insulin API Product Portfolio
  12. 8.2.5 Sanofi-Aventis Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Insulin API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Insulin API Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Tonghua Dongbao
  20. 8.4.1 Tonghua Dongbao Company Information
  21. 8.4.2 Tonghua Dongbao Business Overview
  22. 8.4.3 Tonghua Dongbao Insulin API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tonghua Dongbao Insulin API Product Portfolio
  24. 8.4.5 Tonghua Dongbao Recent Developments
  25. 8.5 Ganlee
  26. 8.5.1 Ganlee Company Information
  27. 8.5.2 Ganlee Business Overview
  28. 8.5.3 Ganlee Insulin API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ganlee Insulin API Product Portfolio
  30. 8.5.5 Ganlee Recent Developments
  31. 8.6 United Laboratory
  32. 8.6.1 United Laboratory Company Information
  33. 8.6.2 United Laboratory Business Overview
  34. 8.6.3 United Laboratory Insulin API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 United Laboratory Insulin API Product Portfolio
  36. 8.6.5 United Laboratory Recent Developments
  37. 8.7 Biocon
  38. 8.7.1 Biocon Company Information
  39. 8.7.2 Biocon Business Overview
  40. 8.7.3 Biocon Insulin API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biocon Insulin API Product Portfolio
  42. 8.7.5 Biocon Recent Developments
  43. 8.8 Amphastar
  44. 8.8.1 Amphastar Company Information
  45. 8.8.2 Amphastar Business Overview
  46. 8.8.3 Amphastar Insulin API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Amphastar Insulin API Product Portfolio
  48. 8.8.5 Amphastar Recent Developments
  49. 8.9 Wockhardt
  50. 8.9.1 Wockhardt Company Information
  51. 8.9.2 Wockhardt Business Overview
  52. 8.9.3 Wockhardt Insulin API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Wockhardt Insulin API Product Portfolio
  54. 8.9.5 Wockhardt Recent Developments
  55. 8.10 Julphar Diabetes
  56. 8.10.1 Julphar Diabetes Company Information
  57. 8.10.2 Julphar Diabetes Business Overview
  58. 8.10.3 Julphar Diabetes Insulin API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Julphar Diabetes Insulin API Product Portfolio
  60. 8.10.5 Julphar Diabetes Recent Developments
  61. 8.11 Torrent Pharma
  62. 8.11.1 Torrent Pharma Company Information
  63. 8.11.2 Torrent Pharma Business Overview
  64. 8.11.3 Torrent Pharma Insulin API Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Torrent Pharma Insulin API Product Portfolio
  66. 8.11.5 Torrent Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin API Value Chain Analysis
  2. 9.1.1 Insulin API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin API Sales Mode & Process
  6. 9.2 Insulin API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin API Distributors
  9. 9.2.3 Insulin API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst